Product Information
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1862 per EA under NDC 00093324101. Its NADAC has been published 351 times since Oct 9, 2019.
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB
bisoprolol fumarate and hydrochlorothiazideStrength
2.5; 6.25 mg/1; mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093324101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020186On Market Since
8/7/2019
Pharmacological Classes
Price Statistics
The NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has been published 351 times since Oct 9, 2019, and over the history we have for it it has declined 59.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1862 per EA |
|---|---|
| All-time high | $0.4639 (Jan 15, 2020) |
| All-time low | $0.1729 (Nov 20, 2024) |
| 52-week high | $0.2138 |
| 52-week low | $0.1855 |
| Median price | $0.3004 |
| Average price | $0.3061 |
| Largest weekly change | +63.0% (Nov 22, 2023) |
| Weeks tracked | 351 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, manufactured by Teva Pharmaceuticals USA Inc., is $0.1862 per EA (NDC 00093324101), effective Jun 24, 2026.
How has the price of BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB changed over time?
Over the history we have for it, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has declined 59.0%. It has been tracked across 351 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
Since Oct 9, 2019, the NADAC for BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB has ranged from a low of $0.1729 (Nov 20, 2024) to a high of $0.4639 (Jan 15, 2020), with a median of $0.3004 per EA.
Are there cheaper alternatives to BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
3 NADAC-published products share the same active ingredient, strength, and dosage form as BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB, but none are currently priced below it.
Who manufactures BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB?
BISOPROLOL-HYDROCHLOROTHIAZIDE 2.5-6.25 MG TB (NDC 00093324101) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification